AlphaValue cuts Arkema to 'add' on demand caution

Arkema SA

09/07/2026 07:46

** Alphavalue cuts France-based chemical Arkema AKE.PA to "add" from "buy", reflecting a combination of lower earnings expectations and a higher multiples-based valuation discount to peers
** The broker says it has become more cautious on demand and pricing, citing subdued consumer confidence and construction activity, as well as pressure on acrylic spreads from lower oil prices
** AlphaValue cuts its 2026 EPS estimate by 9.69% to EUR 4.46 and 2027 EPS by 9.69% to EUR 4.98
** The broker raises its valuation multiples discount to peers to 35% from 20%, as the "more cautious earnings outlook suggests that trading multiples are likely to revert toward their historically discounted range"
** For 2027, AlphaValue says "we have lowered our pricing expectations as oil markets are expected to cool"
** Out of 17 analysts that cover Arkema SA, seven rate the stock "strong buy" or "buy,"​seven rate "hold" and three​ rate the stock "strong sell" or "sell" - LSEG data

 (Reporting by Ronan Corcoran in Gdańsk)
 ((ronan.corcoran@thomsonreuters.com))